Scientists have made a world first breakthrough in the fight against Parkinson’s

content material of the article

This is taken into account a world first in the fight against Parkinson’s illness.

Advertising 2

content material of the article

Ultrasound expertise developed by researchers at Sunnybrook Health Sciences Center and University Health Network is protected for treating focused areas of the mind in sufferers with Parkinson’s illness.

content material of the article

“Our preliminary findings symbolize an thrilling and essential first step in the minimally invasive supply of therapies to key mind areas essential in the improvement and development of Parkinson’s illness,” stated Dr. Nir Lipsman, the examine’s principal investigator and director of Sunnybrook’s Harquail Neuromodulation Center.

“Current methods for managing Parkinson’s embrace medicine and invasive neurosurgery. Focused ultrasound is a much less invasive, focused strategy that would revolutionize the method mind ailments are handled in the future.”

Advertising 3

content material of the article

Low-intensity MRI-guided ultrasound expertise makes use of ultrasound waves to disrupt the blood-brain barrier, a layer that protects the mind from toxins but additionally prevents medicine from attending to the place they’re wanted.

Often, the therapy can not cross the blood-brain barrier as a result of the compounds are too giant.

In some circumstances, open mind surgical procedure is required to assist handle Parkinson’s, a dysfunction of the mind that causes uncontrollable actions and impacts the affected person’s high quality of life.

The researchers studied the supply of the enzyme glucocerebrosidase to the putamen, a key mind construction concerned in motion.

Glucocerebrosidase helps stop the build-up of the protein alpha-synuclein, a key issue in Parkinson’s, which retains mind cells wholesome.

Advertising 4

content material of the article

Featured video

Sorry, however this video did not load.

The first section of the trial included 4 sufferers with a mean age of 54 who have been identified with early stage Parkinson’s illness.

Patients obtained three doses of therapeutic and targeted ultrasound each two weeks to the a part of the mind most affected by Parkinson’s illness.

They have been adopted for 3 and 6 months.

“The section I trial urged a attainable enchancment in the following signs, however this requires additional examine. Any unwanted side effects, corresponding to involuntary actions, have been solely non permanent and none have been extreme,” stated Dr. Lorraine Kalia, principal investigator and neurologist and senior scientist at the UHN Kremlin Brain Institute.

Advertising 5

content material of the article

“The analysis continues to be early, however with the outcomes of our world-first examine, we’re making much-needed progress in creating progressive remedies for individuals with Parkinson’s illness.”

Sunnybrook and UHN researchers have initiated a second section of the trial and are persevering with their investigation.

“The upcoming trial will proceed to research low-intensity MRI-guided targeted ultrasound and focused enzyme alternative remedy to each side of the mind. “The final objective is to ship therapeutic brokers to the mind in hopes of bettering the signs or slowing the development of Parkinson’s illness,” says Dr. Suneil Kalia, principal investigator and neurosurgeon and scientist at UHN.

Advertisement 1


Postmedia strives to keep up a vigorous however civil discussion board for dialogue and encourages all readers to share their ideas on our articles. Comments might be moderated for as much as one hour earlier than showing on the web site. Please preserve your feedback related and respectful. We’ve enabled e-mail notifications — you may obtain an e-mail for those who get a reply to your remark, if there’s an replace on the remark thread you posted, or for those who’re a consumer who subscribed to the feedback. Please go to our Community Guidelines for extra info and data on the right way to alter your e-mail settings.

Leave a Comment

Your email address will not be published. Required fields are marked *